Skip to main content
. 2024 May 15;20(6):4185–4198. doi: 10.1002/alz.13871

FIGURE 1.

FIGURE 1

Flowchart of study design and patient inclusion. APOE, apolipoprotein E; EOAD, early‐onset Alzheimer's disease; MRI, magnetic resonance imaging; SD‐OCTA, spectral domain optical coherence tomography angiography; SS‐OCTA, swept‐source optical coherence tomography angiography.